Global Serum-Free Media Industry Overview
The global market for serum-free media was valued at $1,022.4 million in 2021 and is expected to reach $3,920.5 million by 2032, registering a CAGR of 12.73% during the forecast period 2022-2032. The growth in the global serum-free media market is expected to be driven by factors such as the low risk of contamination in the media, rising awareness of media-based diagnostic testing, and significant number of funding for executing research and development.
Impact
Several techniques are employed in the development of serum-free media utilization for the process of removing cells, tissues, or organs from an animal or plant and putting them into a setting that will help them survive and/or proliferate. The selection of an adequate growth medium for in vitro cultivation is the most significant and important phase in cell culture. A growth medium, also known as a culture media, is a solution, gel, or powder that promotes the development of cells, small plants, or microorganisms. This serum-free medium market space has been segmented into different media types that include common serum-free, xeno-free, chemically-defined, animal component-free, and protein-free. Some of these media types are described in brief as follows:
• Common serum-free media: In common serum-free media, the composition is precisely defined, ensuring lot-to-lot consistency and eliminating the need to screen new lots of serum. In addition to facilitating the growth of numerous cell types for study, serum-free media also provide the advantage of removing the threat of infectious pathogens. The common serum-free media does not include human or animal serum or plasma in its direct or basic constituents.
• Chemically-defined media: Chemically-defined media is beneficial for a range of physiological research as well as for examining the minimal needs of microorganisms. Chemically-defined media are known to increase productivity and reduce costs in cell culture applications. A specified medium will enhance reproducibility and enable a more precise prediction of the final yield from a certain procedure.
• Animal component-free media: Animal-free media, also known as animal component-free and animal origin-free cell culture media, can offer the essential components required for cell growth and performance similar to the media, including serum, but without the drawbacks associated with using the serum. Animal component-free media not only mitigates the risk of prions and other viral contaminants but also improves regulatory approvals and speed-to-market.
• Protein-free media: The protein-free media are ideal for producing proteins as they promote healthy cell development and excellent protein yield. The proteins in the protein-free medium can be substituted with low-molecular-weight components such as peptides, hormones, and inorganic ions. However, protein-free designated commercially available media frequently contain just trace amounts of recombinant proteins.
View Report -Global Serum-Free Media Market
Recent Developments in the Global Serum-Free Media Market
• In August 2022, Thermo Fisher Scientific Inc. expanded the cell culture media manufacturing facility in Grand Island, New York, to support the production of new vaccines and biologics. This expansion would support the worldwide media supply and increase the capacity to create high-quality technologies.
• In May 2022, FUJIFILM Irvine Scientific completed its new bioprocessing innovation and collaboration center in China. The new center would enable local resources and expertise required to optimize cell culture media and workflows to aid the production of vaccines, advanced therapies, and biotherapeutic drug development in China.
• In September 2021, Bio-Techne Corporation developed a new medium ExCellerate IpsC expansion medium, for IpsC research in regenerative medicine.
• In April 2021, PromoCell GmbH launched an upgrade to its Keratinocyte Cell Culture Portfolio. The company expanded its improved animal-extract-free Keratinocyte Growth Medium 3 for the standardized isolation and development of juvenile and adult Normal Human Keratinocytes.
• In March 2021, the company also launched its improved third-generation Melanocyte Cell Culture Portfolio. Melanocyte Growth Medium M3 is a serum-free, bovine pituitary extract (BPE)-free, and phorbol myristate acetate (PMA)-free media formulation.
Demand – Drivers and Limitations
Following are the demand drivers for the global serum-free media market:
• Low Risk of Contamination as a Demand Driver
• Launch of innovative products in Serum-Free Media Ecosystem
• Low reception cost involving small and medium enterprises in comparison to animal derived media
The market is expected to face some limitations too due to the following challenges:
• Slow Growth Rate in Comparison to Serum-Supplemented Media
• Requirement of Diverse Cell-Type for Specific Media Formulation
Key Market Players and Competition Synopsis
The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.
Some of the prominent names established in this market are:
Company Type 1: Serum-Free Media Private Industry
• MP BIOMEDICALS.
• HiMedia Laboratories
• R&D Systems, Inc.
• Sino Biological, Inc.
• PAN-Biotech.
• PromoCell GmbH
• Athena Environmental Sciences, Inc.
• STEMCELL Technologies Inc.
Company Type 2: Serum-Free Media Public Industry
• Corning Incorporated
• Lonza Group AG
• Merck KgaA
• Sartorius AG
• Thermo Fisher Scientific Inc.
• FUJIFILM Holdings Corporation
• Danaher.
Get Free Sample Report - https://bisresearch.com/requestsample?id=1361&type=download
How can this report add value to an organization?
Product/Innovation Strategy: The report considers serum-free media products from product-based companies. These companies are actively involved in undertaking significant business strategies to translate success in research and development into the commercial clinical setting.
Growth/Marketing Strategy: Owing to the explosion of massively parallel cell therapy and gene editing, all areas of healthcare have been affected, particularly serum-free media-based cellular diagnostics. The key components in the serum-free media market consist of a diverse range of media types as products. The entire workflow is well explained in the report, along with pricing analysis considering the applications that are used in testing.
Competitive Strategy: Key players in the global serum-free media market were analyzed and profiled in the study, consisting of both products-based companies as well as a few emerging companies. Moreover, a detailed competitive benchmarking of the players operating in the global serum-free media market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.
BIS Related Studies
The landscape of cell culture growth is generating demand for serum free media.
And, this is all set to bring about a notable growth in the global serum free media market.
Another factor that will shape up the outlook for the forecast period includes growing demand for immunotherapy on a global level.The report provides a comprehensive analysis of trends and drivers, regional outlook, competitive landscape, strategies and so on.
As, this would ensure a well informed decision making for better outcomes.Read Report Overview –https://www.transparencymarketresearch.com/serum-free-media-market.htmlGlobal Serum Free Media Market: Key Trends and DriversOver the forecast period, the global serum free media market will chart an upward growth trajectory owing to increase in incidences of chronic diseases, rise in infections, and growth in the number of people who are occupying the geriatric age group which will see an additional two billion people belonging to the age bracket of 60 an above in another 30 years.
It is also worth noting here that four in every ten people in the United States alone, are suffering from more than one chronic disease; six in every ten are suffering from at least one.
All this is leasing to an increase in demand for immunotherapy, aiding in the growth of serum free media market.It is noteworthy here that a pipeline of pharmaceuticals and biologics marks the pharmaceutical industry, making the future of the industry promising.
DecisionDatabases recently present the global Serum-Free Freezing Media Market research report 2020 which reveals an extensive analysis of the global industry by delivering detailed information about upcoming market growth, trends, customer expectations, technological improvements, competitive dynamics, top manufacturers' assessment, and working capital in the industry.
The global serum-free freezing media market report presents a complete research-based study of the industry including details such as company shares, forecast data, in-depth analysis and an outlook of the market on a worldwide platform.
The report further highlights the market drivers, restraints and the top manufacturers at the global and regional levels.
Get FREE Sample Report Copy @ https://www.decisiondatabases.com/contact/download-sample-43302 According to this study, over the next five years, the Serum-Free Freezing Media market will register a 10.0% CAGR in terms of revenue, the global market size will reach $ 290.6 million by 2025, from $ 198.8 million in 2019.
The key manufacturers covered in this report: Breakdown data in Chapter 3.
Thermo FisherMerckZenoaqSTEMCELLGE HealthcareBioLifeSolutionsBio-TechneLonzaBiological IndustriesNippon GeneticsHiMediaPromoCellOthers View More about this Market @ Global Serum-Free Freezing Media Industry Report This study considers the Serum-Free Freezing Media value and volume generated from the sales of the following segments: Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
